Moderna Seeks US FDA Approval for Use of Covid Vaccine in Adolescents

Moderna has sought the US FDA's emergency authorization for its mRNA Covid-19 vaccine for use in adolescents. Last month the FDA cleared Pfizer's request for use of its Covid-19 vaccine in adolescents.

Moderna, a US-based pharmaceutical and biotechnology company has sought the US Food and Drug Administration's (FDA) approval for the emergency use of its mRNA Covid-19 vaccine for in adolescents 12-to 17-year-olds.

"We are pleased to //announce that we have submitted for an emergency use authorization for our Covid-19 vaccine with the FDA for use in adolescents in the United States," Moderna CEO Stephane Bancel said in a statement on Thursday.

MRNA COVID Vaccines Effective for Pregnant, Lactating Women
COVID-19 mRNA vaccines triggers immune responses in pregnant and lactating women. And, Maternal vaccine antibodies are transferred into infant cord blood and breast milk.

‘Last month the FDA cleared Pfizer's request for use of its Covid-19 vaccine in adolescents and about 7 million children under 18 have received at least one dose of the vaccine so far.’

"We are encouraged that the Moderna Covid-19 vaccine was highly effective at preventing Covid-19 and SARS-CoV-2 infection in adolescents," Bancel added.

The Moderna Covid-19 Vaccine was approved for emergency use in the US in December. Its application to the US FDA for young teenagers is based on a study, which enrolled 3,732 children ages 12 to 17 years. Of these, 2,500 received two doses of the vaccine and the remaining a saltwater placebo.

The results reported last month showed Moderna's Covid-19 vaccine was effective in adolescents. There were no cases of symptomatic Covid-19 among vaccine recipients, Moderna said, suggesting 100 per cent vaccine efficacy in adolescents, though overall very few among the 3,700 children in the study got sick.

mRNA COVID-19 Vaccines Seen as Most Promising: GlobalData
Nearly 38 percent of healthcare participants felt that mRNA COVID-19 vaccines are the most promising of the vaccine technologies, noticeably beating DNA vaccines, according to GlobalData survey.

The company has already filed for authorization with Health Canada and the European Medicines Agency, and plans to seek approval in other countries.

Last week, the company applied to the US FDA for full approval for its mRNA Covid-19 vaccine for use in people 18 and older.

Taste Perception Is Affected By Variation in Bitter Receptor MRNA Expression
Have you ever wondered why you love chomping on raw broccoli while your best friend can't stand the healthy veggie in any form or guise?

In May, Moderna was also added to the list of World Health Organization (WHO) for emergency use, making it the fifth vaccine to receive emergency validation from the WHO. The WHO's Strategic Advisory Group of Experts on Immunization (SAGE), found the mNRA-based vaccine to have an efficacy of 94.1 per cent.

In addition, the company is also planning a third booster shot. According to data from its Phase 2 study, antibodies produced by a single 50 mg dose of its booster shot was effective against the original form of the virus, as well as against two variants of concern Beta (B1351) and Gamma (P1) first identified in South Africa and Brazil.

Scientists Identify Global Regulator of mRNA Editing
A protein that broadly regulates how genetic information transcribed from DNA to messenger RNA (mRNA) is processed has been discovered by researchers.

Last month the FDA cleared Pfizer's request for use of its Covid-19 vaccine in adolescents. About 7 million children under 18 have received at least one dose of the vaccine so far, and about 3.5 million are fully protected, according to the US Centers for Disease Control and Prevention (CDC).

Source-IANS